Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole

Chagas disease remains a major social and public health problem in Latin America. Benznidazole (BZN) is the main drug with activity against Trypanosoma cruzi. Due to the high number of adverse drug reactions (ADRs), BZN is underprescribed. The goal of this study was to evaluate the genetic and trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Franco, Lucas A. M., Moreira, Carlos H. V., Buss, Lewis F., Oliveira, Lea C., Martins, Roberta C. R., Manuli, Erika R., Lindoso, José A. L., Busch, Michael P., Pereira, Alexandre C., Sabino, Ester C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920452/
https://www.ncbi.nlm.nih.gov/pubmed/33669428
http://dx.doi.org/10.3390/ijms22041960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920452/
https://www.ncbi.nlm.nih.gov/pubmed/33669428
http://dx.doi.org/10.3390/ijms22041960

Ejemplares similares